Literature DB >> 21317990

Surveillance for hepatocellular carcinoma: in whom and how?

Hashem B El-Serag1, Jessica A Davila.   

Abstract

Entities:  

Year:  2011        PMID： 21317990      PMCID： PMC3036965          DOI： 10.1177/1756283X10385964

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN： 1756-283X            Impact factor:   4.409


× No keyword cloud information.
  36 in total

1.  Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America.

Authors:  M J Tong; L M Blatt; V W Kao
Journal:  J Gastroenterol Hepatol       Date:  2001-05       Impact factor: 4.029

2.  Screening methods for early detection of hepatocellular carcinoma.

Authors:  K Kobayashi; T Sugimoto; H Makino; M Kumagai; M Unoura; N Tanaka; Y Kato; N Hattori
Journal:  Hepatology       Date:  1985 Nov-Dec       Impact factor: 17.425

Review 3.  Hepatocellular carcinoma and hepatitis C in the United States.

Authors:  Hashem B El-Serag
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

4.  Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival.

Authors:  Luci K Leykum; Hashem B El-Serag; John Cornell; Kyriakos P Papadopoulos
Journal:  Clin Gastroenterol Hepatol       Date:  2007-03-26       Impact factor: 11.382

5.  Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).

Authors:  Franco Trevisani; Stefania De Notariis; Gianludovico Rapaccini; Fabio Farinati; Luisa Benvegnù; Marco Zoli; Gian Luca Grazi; Poggio Paolo Del; NolfoMariaAnna Di; Mauro Bernardi
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

6.  Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.

Authors:  Jessica A Davila; Louise Henderson; Jennifer R Kramer; Fasiha Kanwal; Peter A Richardson; Zhigang Duan; Hashem B El-Serag
Journal:  Ann Intern Med       Date:  2011-01-18       Impact factor: 25.391

7.  Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.

Authors:  Derek Patel; Norah A Terrault; Francis Y Yao; Nathan M Bass; Uri Ladabaum
Journal:  Clin Gastroenterol Hepatol       Date:  2005-01       Impact factor: 11.382

8.  Follow-up examination schedule of postoperative HCC patients based on tumor volume doubling time.

Authors:  S Okada; N Okazaki; H Nose; K Aoki; N Kawano; J Yamamoto; K Shimada; T Takayama; T Kosuge; S Yamasaki
Journal:  Hepatogastroenterology       Date:  1993-08

9.  Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival.

Authors:  Franco Trevisani; Maria C Cantarini; Antonello M M Labate; Stefania De Notariis; Gianludovico Rapaccini; Fabio Farinati; Paolo Del Poggio; Maria Anna Di Nolfo; Luisa Benvegnù; Marco Zoli; Franco Borzio; Mauro Bernardi
Journal:  Am J Gastroenterol       Date:  2004-08       Impact factor: 10.864

10.  Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.

Authors:  Jorge A Marrero; Ziding Feng; Yinghui Wang; Mindie H Nguyen; Alex S Befeler; Lewis R Roberts; K Rajender Reddy; Denise Harnois; Josep M Llovet; Daniel Normolle; Jackie Dalhgren; David Chia; Anna S Lok; Paul D Wagner; Sudhir Srivastava; Myron Schwartz
Journal:  Gastroenterology       Date:  2009-04-09       Impact factor: 22.682
View more
  46 in total

1.  Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer.

Authors:  M Walker; H B El-Serag; Y Sada; S Mittal; J Ying; Z Duan; P Richardson; J A Davila; F Kanwal
Journal:  Aliment Pharmacol Ther       Date:  2016-01-19       Impact factor: 8.171

Review 2.  Management of hepatocellular carcinoma.

Authors:  P Fitzmorris; M Shoreibah; B S Anand; A K Singal
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-27       Impact factor: 4.553

Review 3.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

4.  Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan.

Authors:  Masatoshi Kudo; Namiki Izumi; Michiie Sakamoto; Yutaka Matsuyama; Takafumi Ichida; Osamu Nakashima; Osamu Matsui; Yonson Ku; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Liver Cancer       Date:  2016-05-10       Impact factor: 11.740

5.  Liver cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

Authors:  Behnoosh R Momin; Paulo S Pinheiro; Helena Carreira; Chunyu Li; Hannah K Weir
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

Review 6.  Role of surveillance in prevention of hepatocellular carcinoma.

Authors:  Dipanjan Panda
Journal:  J Clin Exp Hepatol       Date:  2014-05-25

7.  Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with Cirrhosis.

Authors:  Winston E Abara; P Spradling; Y Zhong; A Moorman; E H Teshale; L Rupp; S C Gordon; M Schmidt; J A Boscarino; Y G Daida; S D Holmberg
Journal:  J Gastrointest Cancer       Date:  2020-06

8.  Hepatocellular carcinoma surveillance: the often-neglected practice.

Authors:  Jennifer Sammon; Korosh Khalili
Journal:  Hepatobiliary Surg Nutr       Date:  2020-02       Impact factor: 7.293

9.  Anticancer effect of fufang yiliu yin on human hepatocellular carcinoma SMMC-7721 cells.

Authors:  Zhenjie Yang; Shigao Zhu; Shihai Liu; Xue Wang; Bing Han; Bingyuan Zhang; Xiao Hu; Ruyong Yao; Chuandong Sun; Chengzhan Zhu
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

10.  Integrative genomic analysis of mouse and human hepatocellular carcinoma.

Authors:  Michelle Dow; Rachel M Pyke; Brian Y Tsui; Ludmil B Alexandrov; Hayato Nakagawa; Koji Taniguchi; Ekihiro Seki; Olivier Harismendy; Shabnam Shalapour; Michael Karin; Hannah Carter; Joan Font-Burgada
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-04       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.